Intuitive Surgical: Great Company, But Looking Overpriced

Intuitive Surgical's flagship da Vinci system 3alexd/E+ via Getty Images Intuitive Surgical, Inc. (NASDAQ:ISRG) has been on a tear over the last 12 months, up 61% since March last year. Revenues rebounded in 2023 to $7.1bn with 14% YoY growth, driven by a 21% increase in procedure volume of their flagship da Vinci system. The company is also in an excellent financial position with$ 5.2bn in cash and zero debt. However, with a P/E of 78.8 and an EV/EBITDA of 62.4 it may be looking expensive, and there are ...